ArticleNeuropsychiatric disease and treatment2024

Clinical Features and Prognostic Analysis of MuSK-Antibody-Positive Myasthenia Gravis versus Double-Seropositive Myasthenia Gravis: A Single-Center Study from Central South China.

Ting He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.